Date: 02.08.2007 Alpa Laboratories Limited is in the business of manufacturing of pharmaceutical formulations. Alpa manufacture a range of products such as ethical drugs, generic drugs, over the counter drugs (OTC) and veterinary products in various dosage forms. It also manufacture formulations for a number of other pharmaceutical companies of national and international repute such as Cipla, Zydus Cadila, Lupin, Glenmark, Genom Biotech, Jenburkt, etc. (under their own brands).
Alpa Laboratories manufacture various dosage forms which include injectables (vials / ampoules both liquid and dry), tablets, capsules, eye / ear drops, ointment and creams and dry syrups.
Objects of the Issue:The objects of the Issue are to achieve the benefits of listing on the Stock Exchanges & to raise capital for
Setting up a new plant at Pigdamber, Indore for increasing our production & testing capacities;
Meeting Margin money working capital requirements.
»» Public Issue Open : July 12, 2007 to July 17, 2007
»» Public Issue Type : 100% Book Building Issue (Initial Public Offer IPO )
»» Public Issue Size: 95,00,000 Equity Shares of Rs.10/- each
»» Public Issue Price: Rs. 62/- to Rs. 68/- Per Equity Share
»» Market Lot: 100 Shares
»» Minimum Order Quantity: 100 Shares
»» Maximum Subscription Amount for Retail Investor: Rs 100,000/-
»» Listing : BSE, NSE